Skip to content

Insider · CIK 0001106508

William A Hawkins

director

Files at BIIB (BIOGEN INC.), MDXG (MIMEDX GROUP, INC.), BVS (Bioventus Inc.). First filing -, latest -.

William A Hawkins files SEC Form 4 as director at BIIB (BIOGEN INC.), and also at MDXG (MIMEDX GROUP, INC.), BVS (Bioventus Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; William A Hawkins has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 10 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 10, 2026MDXG
MIMEDX GROUP, INC.
AGrant or award
Common Stock
+50,913$3.64$185k254,931Jun 12, 2026
Jun 9, 2026BIIB
BIOGEN INC.
AGrant or award
Common Stock
+1,505$0.00$010,365Jun 11, 2026
Jun 2, 2026BVS
Bioventus Inc.
MOption exercise
Class A Common Stock
+39,789$0.00$0297,640Jun 4, 2026
Jun 2, 2026BVS
Bioventus Inc.
MOption exercise
Restricted Stock Unitsderivative
-39,789$0.00$00Jun 4, 2026
Jun 3, 2026BVS
Bioventus Inc.
AGrant or award
Restricted Stock Unitsderivative
+30,994$0.00$030,994Jun 4, 2026
Jun 18, 2025MDXG
MIMEDX GROUP, INC.
AGrant or award
Common Stock
+28,609$6.47$185k204,018Jun 23, 2025
Jun 17, 2025BIIB
BIOGEN INC.
AGrant or award
Common Stock
+2,370$0.00$08,860Jun 18, 2025
Jun 2, 2025BVS
Bioventus Inc.
MOption exercise
Class A Common Stock
+26,493$0.00$0257,851Jun 4, 2025
Jun 2, 2025BVS
Bioventus Inc.
MOption exercise
Restricted Stock Unitsderivative
-26,493$0.00$00Jun 4, 2025
Jun 3, 2025BVS
Bioventus Inc.
AGrant or award
Restricted Stock Unitsderivative
+39,789$0.00$039,789Jun 4, 2025

Questions about William A Hawkins

Answered from the filings on this page, as of the latest one.

Is William A Hawkins buying or selling?

William A Hawkins has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did William A Hawkins's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William A Hawkins has 0.

Where does William A Hawkins file Form 4?

William A Hawkins has filed Form 4 at BIIB (BIOGEN INC.); MDXG (MIMEDX GROUP, INC.); BVS (Bioventus Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

William A Hawkins: insider trades and track record | InsiderTell